back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-03-19 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+12,500 vol |
14,167 | |
| Filed 2018-03-19 Tx date 2017-11-30 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-19 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+80,286 vol |
80,286 | |
| Filed 2018-03-19 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,457.75
-833 vol $1.75 each |
1,667 | |
| Filed 2018-03-19 Tx date 2017-11-30 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-19 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,457
+833 vol $1.75 each |
833 | |
| Filed 2018-03-19 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
117,500 | |
| Filed 2017-12-04 Tx date 2017-11-30 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
92,500 | |
| Filed 2017-12-04 Tx date 2017-11-30 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
2,500 | ||
| Filed 2017-12-04 Tx date 2017-11-30 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kaseta, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
67,500 |